Skip to main content
. 2016 Feb;22(2):247–254. doi: 10.3201/eid2202.141732

Table 1. Clinical manifestations and age of patients with invasive Streptococcus dysgalactiae subsp. equisimilis infection, Japan, April 2010–March 2013*.

Clinical manifestation No. (%) cases by age, y
Total no. (%) cases p value†
<18 18–59 ≥60 ≥70 ≥80 ≥90
Cellulitis 1 (0.4) 36 (15.4) 26 (11.1) 59 (25.2) 78 (33.3) 34 (14.5) 234 (33.8) 0.702
Pneumonia 2 (4.9) 4 (9.8) 5 (12.2) 18 (43.9) 12 (29.3) 41 (5.9) 0.006
Arthritis 1 (2.1) 11 (23.4) 9 (19.1) 13 (27.7) 8 (17.0) 5 (10.6) 47 (6.8) 0.076
Abscess, noncutaneous 1 (3.2) 13 (41.9) 5 (16.1) 5 (16.1) 5 (16.1) 2 (6.5) 31 (4.5) <0.001
Endocarditis 3 (27.3) 5 (45.5) 2 (18.2) 1 (9.1) 11 (1.6)
Meningitis 1 1 3 1 6 (0.9)
STSS 1 1 1 3 (0.4)
Necrotizing fasciitis 1 (6.3) 3 (18.8) 3 (18.8) 3 (18.8) 4 (25.0) 2 (12.5) 16 (2.3) 0.803
Cholangitis/peritonitis 2 (14.3) 1 (7.1) 5 (35.7) 5 (35.7) 1 (7.1) 14 (2.0) 0.740
Osteomyelitis/spondylitis 2 (14.3) 5 (35.7) 4 (28.6) 3 (21.4) 14 (2.0)
Bacteremia without primary focus 1 (0.4) 30 (11.1) 39 (14.4) 58 (21.5) 97 (35.9) 45 (16.7) 270 (39.0) 0.058
Others‡

1
1
3
1

6 (0.9)

Total 6 (0.9) 105 (15.2) 94 (13.6) 164 (23.7) 221 (31.9) 103 (14.9) 693 (100)

*STSS, streptococcal toxic shock syndrome; –, not determined because of small number of strains. Blank cells indicate 0.
†p values were calculated for differences between the 5 age groups, except the <18 y group.
‡Lymphangitis (n = 5) and keratitis (n = 1).